| Fibrocartilaginous mesenchymoma of bone | |
|---|---|
| Specialty | Oncology  |
Fibrocartilaginous mesenchymoma of bone (FCMB) is an extremely rare tumor first described in 1984.[1][2] About 26 cases have been reported in literature, with patient ages spanning from 9 to 25 years, though a case in a male infant aged 1 year and 7 months has been reported.[3][4] Quick growth and bulky size are remarkable features of this tumor.
- ^ Dahlin DC, Bertoni F, Beabout JW, Campanacci M (1984). "Fibrocartilaginous mesenchymoma with low-grade malignancy". Skeletal Radiology. 12 (4): 263–9. doi:10.1007/bf00349507. PMID 6505732. S2CID 12622136.
- ^ Cozzutto C, Cornaglia-Ferraris P (March 1991). "Fibrocartilaginous mesenchymoma of bone". Pathology, Research and Practice. 187 (2–3): 279–83. doi:10.1016/S0344-0338(11)80784-3. PMID 2068011.
- ^ Gambarotti M, Righi A, Vanel D, Cocchi S, Benini S, Elli FM, et al. (July 2017). "Fibrocartilaginous mesenchymoma of bone: a single-institution experience with molecular investigations and a review of the literature". Histopathology. 71 (1): 134–142. doi:10.1111/his.13201. hdl:11577/3223054. PMID 28239886. S2CID 4787327.
- ^ Hayes SJ, Wells S, Harake J, Henderson JJ, Malcolm AJ (July 2005). "Fibrocartilagenous mesenchymoma of bone: the youngest reported case in a patient aged 1 year and 7 months". Journal of Clinical Pathology. 58 (7): 782–3. PMC 1770726. PMID 15976352.